Effect of Hyperuricaemia on Chronic Renal Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03425708|
Recruitment Status : Unknown
Verified January 2018 by The Affiliated Hospital of Xuzhou Medical University.
Recruitment status was: Recruiting
First Posted : February 7, 2018
Last Update Posted : February 7, 2018
|Condition or disease||Intervention/treatment||Phase|
|Hyperuricemia Chronic Renal Disease||Drug: 20mg Febuxostat Drug: 40mg Febuxostat||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||400 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Study on the Effect of Hyperuricaemia on Chronic Renal Disease and Intervention|
|Actual Study Start Date :||January 1, 2017|
|Estimated Primary Completion Date :||December 31, 2018|
|Estimated Study Completion Date :||December 31, 2018|
Active Comparator: Treatment group1
Febuxostat pill 20mg was used to treat CKD patients with hyperuricaemia.
Drug: 20mg Febuxostat
Participants take 20mg febuxostat pill once a day for at least six months.
Other Name: 20mg Febuxostat pill group
Active Comparator: Treatment group2
Febuxostat pill 40mg was used to treat CKD patients with hyperuricaemia.
Drug: 40mg Febuxostat
Participants take 40mg febuxostat pill once a day for at least six months.
Other Name: 40mg Febuxostat pill group
No Intervention: Control group
Treatment of CKD patients with hyperuricaemia with conventional methods.
- serum uric acid [ Time Frame: up to 6 months ]intravenous blood sampling
- serum creatinine [ Time Frame: up to 6 months ]intravenous blood sampling
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03425708
|Contact: Dong Sun, MDemail@example.com|
|The Affiliated Hospital of Xuzhou Medical University||Recruiting|
|Xuzhou, Jiangsu, China, 221000|
|Contact: Dong Sun, MD 15862158578 firstname.lastname@example.org|
|Study Director:||Dong Sun, MD||Affiliated Hospital of Xuzhou Medical University|